Frizzled-4

Frizzled-4 Overview

English NameFrizzled-4Approved Drugs0
Drugs in Clinical Trials1Target SynonymhFz4,FzE4,CD344,Frizzled 4, Seven Transmembrane Spanning Receptor,Fz-4,Frizzled Family Receptor 4,EVR1,Frizzled (Drosophila) Homolog 4,Frizzled Homolog 4 (Drosophila),Exudative Vitreoretinopathy 1,WNT Receptor Frizzled-4,Frizzled Homolog 4,CD344 Antigen,FZD4S,FEVR,GPCR,Fz4
Highest Development StagePhase 3 Clinical
English NameFrizzled-4
Target SynonymhFz4,FzE4,CD344,Frizzled 4, Seven Transmembrane Spanning Receptor,Fz-4,Frizzled Family Receptor 4,EVR1,Frizzled (Drosophila) Homolog 4,Frizzled Homolog 4 (Drosophila),Exudative Vitreoretinopathy 1,WNT Receptor Frizzled-4,Frizzled Homolog 4,CD344 Antigen,FZD4S,FEVR,GPCR,Fz4
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 3 Clinical

Frizzled-4 Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    Fc Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (1)Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
FZ4-H5250
Human
HEK293
Human Frizzled-4 / FZD4 Protein, Fc Tag
FZ4-H82E3
Human
HEK293
Biotinylated Human Frizzled-4 / FZD4 Protein, His,Avitag™ (MALS verified)
Total: 2
  • 1

Frizzled-4 Background

Frizzled-4 (FZD4) is also known as FzE4, CD344, which belongs to the G-protein coupled receptor Fz/Smo family. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. FZD4 contains one FZ (frizzled) domain. FZD4 may be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. FZD4 interacts with MAGI3 and norrin (NDP).

Frizzled-4 Synonyms

FZD4,Frizzled-4,CD344,Fz-4,hFz4,FzE4

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
RestoretEYE103; EYE-103; MK-3000; ANT-39Phase 3 ClinicalEyebiotech LtdDiabetic macular oedema; Macular Degeneration; Retinal Vein Occlusion
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8